Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.

Zhenyi Wang, Guan-Lin Sun, Zhixiang Shen, Sai‐Juan Chen, Zhu ChenPubMed 1999

Abstract

The combination of ATRA, chemotherapy and arsenic oxide in the treatment of APL for elevating the remission rate and prolonging survival time deserves further study.
BibTeX
@inproceedings{wang1999differentiation,
  author = {Zhenyi Wang and Guan-Lin Sun and Zhixiang Shen and Sai‐Juan Chen and Zhu Chen},
  title = {{Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.}},
  booktitle = {PubMed},
  year = {1999},
}

Loading related content...

Figure